Clinical Nutrition Market worth USD 57,456.8 million by 2030

The Market Statsville Group (MSG) publishes the new report on the "Clinical Nutrition Market by Route of Administration (Oral, Enteral, and Parenteral), by Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, and Others), by End-Users (Pediatric, Adults, and Geriatric), by Region – Global Share and Forecast to 2030".

The global clinical nutrition market size was USD 33,721.24 million in 2021 and is estimated to reach USD 57,456.8 million by 2030. The market is projected to grow at a CAGR of 6.1% during the study period. Clinical nutrition deals with the diagnosis and treatment of disease related to the nutritional deficiency that affects a person's intestinal absorption and metabolism. Clinical nutritionists generally work in acute and ambulatory care settings for many diseases such as cardiac rehabilitation, renal dialysis, cancer, and diabetes. The clinical nutrition market is expected to exhibit significant growth during the forecast period due to an increase in the prevalence of chronic disorders & lifestyle-related disorders and rise in the number of patients using advanced clinical nutritional products globally.

In addition, the rise in R&D investments made by the government in healthcare are the major factors that boost the global clinical nutrition market. However, lack of awareness and stringent regulations are projected to impede market growth. Moreover, the rise in clinical nutrition advancement and demand for clinical nutrition in emerging regions such as Asia-Pacific are expected to offer significant profitable opportunities for the manufacturers in the global clinical nutrition market.

Scope of Global Clinical Nutrition Market

The clinical nutrition market has been characterized as administration, application, end-users, and region.

• By Route of Administration (Enteral, Oral, and Parenteral)
• By Application (Neurological Diseases, Cancer, Metabolic Disorders, Gastrointestinal Disorders, and Others)
• By End-Users (Pediatric, Adults, and Geriatric)
• By Region (North America, South America, Europe, Asia Pacific, and the Middle East & Africa)

Gastrointestinal disorders, by application, is estimated to hold the largest market share

Based on application, the clinical nutrition market is divided into five segments, namely, cancer, neurological diseases, gastrointestinal disorders, metabolic disorders, and others. In 2021, the gastrointestinal disorders segment was the highest contributor to the market, with a market share of 36.9%. Gastrointestinal (GI) diseases refer to the diseases involving different parts of the GI tract and the accessory organs of digestion like the liver, pancreas, and gallbladder. Many gastrointestinal diseases have nutritional effects such as diarrhea, abdominal pain, abdominal distention, gastrointestinal bleeding, intestinal obstruction, malabsorption, gastrointestinal reflux disease, or malnutrition.

Furthermore, According to World Health Organization (WHO), Gastrointestinal reflux diseases account for approximately 8 million deaths per year worldwide and in the U.S., it is estimated about 60 to 70 million citizens get affected annually, out of which 20% of adults in western culture. Moreover, mainly the diseases of liver and pancreas such as food allergy, disaccharidase intolerance, and gluten-sensitive enteropathy need clinical nutrition. Companies such as Nestlé S.A. provide gastrointestinal nutrition products. Further, a surge in many clinical trials for gastrointestinal disorders offers a lucrative opportunity for gastrointestinal products during the forecast period.

Don't miss out on business opportunities in Clinical Nutrition Market. Speak to our research analyst and gain crucial market insights that will benefit your business grow.

North America accounts for the largest market share in the clinical nutrition market

Based on the regions, the global clinical nutrition market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021, North America accounted for the highest market share of 34.5% in the global clinical nutrition market and was anticipated to maintain its dominance throughout the forecast period. The North America market is analyzed with respect to three countries—the U.S., Canada, and Mexico. North America is projected to grow at a high pace during the forecast period.

The major trend in the North America clinical nutrition market is continuous R&D toward developing innovative clinical nutrition. Further, for a number of chronic diseases, such as coronary artery disease, ischemic stroke, diabetes, and a few cancer indications. The demand of medical nutrition therapy has increased due to the rise in the prevalence of diabetes. According to Canada Diabetes Association in Canada 2020, the estimated prevalence of diabetes was 3.4 million or 9.3% of the population and is predicted to rise to 5 million or 12.1% of the population by 2027.

This research report includes an examination of the leading companies in the clinical nutrition market's development and marketing strategies, as well as an examination of their product portfolios and winning strategies. It also consists of the profiles of leading companies such as Abbott Laboratories, Baxter International Inc., B. Braun Melsungen AG, Danone Nutricia, Perrigo Company Plc., Nestlé S.A., Pfizer Inc., Lonza Ltd., Fresenius SE & Co. KGaA, and Hero Nutritionals Inc. These market players have focused on acquisitions and expansion to gain a larger market share in the clinical nutrition market.

Browse complete report: https://www.marketstatsville.com/clinical-nutrition-market

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group

416, East Standsberry Street, Perkins, Oklahoma 74059, USA

USA: +1-580-205-2707 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com